Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

What happened to the need to end commuting and presenteeism? Or to our gratitude for healthcare workers or our resolution to ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Sell rating on Moderna (MRNA – Research Report), with a ...

The announcement comes as Moderna charts a path forward after the rapid decline in demand for its Covid vaccine. Moderna now expects 2025 revenue of between $1.5 billion and $2.5 billion, most of ...

Copyright 2025 The Associated Press. All Rights Reserved. A local resident receives the Moderna COVID-19 vaccine shot at a ...

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...